Key result
The highest quartile of the Chinese Visceral Adiposity Index was associated with a significantly increased risk of asymptomatic hyperuricemia in patients with type 2 diabetes compared to the lowest quartile (OR 4.990).
Why the study?
High visceral fat correlates with hyperuricemia, but the relationship between the Chinese Visceral Adiposity Index and asymptomatic hyperuricemia in type 2 diabetes patients required investigation.
Does a higher Chinese Visceral Adiposity Index (CVAI) correlate with an increased incidence of asymptomatic hyperuricemia in patients with type 2 diabetes?
Cross-Sectional (n=1,588)
No
Does a higher Chinese Visceral Adiposity Index (CVAI) correlate with an increased incidence of asymptomatic hyperuricemia in patients with type 2 diabetes?
Higher Chinese Visceral Adiposity Index (CVAI) is independently associated with an increased risk of asymptomatic hyperuricemia in patients with type 2 diabetes, suggesting its utility as a predictive clinical marker.
Answers are grounded in this paper and cite their sources.
May inform hyperuricemia risk assessment in T2D; leaves open need for longitudinal validation of visceral adiposity index.
Background Previous research has shown a correlation between high visceral fat levels and hyperuricemia incidence. The Chinese Visceral Adiposity Index (CVAI) assessed visceral fat status in the Chinese population. Our study investigates the correlation between CVAI and asymptomatic hyperuricemia in type 2 diabetes patients. Methods This cross-sectional study analyzed 1,588 hospitalized type 2 diabetes patients to investigate the association between CVAI and hyperuricemia. CVAI was included in the logistic regression analysis as both a continuous and categorical variable, and restricted cubic splines were used to assess the dose-response relationship. Additionally, subgroup analyses were performed to investigate potential interactions among variables. The predictive capability of CVAI was assessed using the receiver operating characteristic (ROC) curve based on the basic model. Results The CVAI quartile group analysis revealed a higher prevalence of hyperuricemia with increasing CVAI levels. CVAI is significantly associated with hyperuricemia, as identified through multifactorial logistic regression analysis. After adjusting for all covariates, the odds ratios for CVAI in the second, third, and fourth quartiles were significantly higher than in the lowest quartile, with values of 2.688 (95% CI [1.301–5.554], p = 0.008), 2.752 (95% CI [1.320–5.739], p = 0.007), and 4.990 (95% CI [2.392–10.409], p < 0.001), respectively. No significant interactions were observed in the subgroup analysis. Incorporating CVAI into the basic model increased the ROC curve’s area under the curve to 0.714. Conclusion This study found a positive correlation between CVAI and hyperuricemia incidence in type 2 diabetes patients. Consequently, CVAI may reliably indicate hyperuricemia in this patient population.
No takes yet. Share an insight, caveat, or question.
Wáng et al. (2025) conducted a cross-sectional in Type 2 diabetes (n=1,588). Chinese Visceral Adiposity Index (CVAI) vs. Lowest quartile of CVAI was evaluated on Asymptomatic hyperuricemia (OR 4.990, 95% CI 2.392-10.409, p=<0.001). The highest quartile of the Chinese Visceral Adiposity Index was associated with a significantly increased risk of asymptomatic hyperuricemia in patients with type 2 diabetes compared to the lowest quartile (OR 4.990).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: